162 related articles for article (PubMed ID: 25128192)
1. Novel approaches to target NF-κB and other signaling pathways in cancer stem cells.
Ukaji T; Umezawa K
Adv Biol Regul; 2014 Sep; 56():108-15. PubMed ID: 25128192
[TBL] [Abstract][Full Text] [Related]
2. Targeting of nuclear factor kappaB Pathways by dehydroxymethylepoxyquinomicin, a novel inhibitor of breast carcinomas: antitumor and antiangiogenic potential in vivo.
Matsumoto G; Namekawa J; Muta M; Nakamura T; Bando H; Tohyama K; Toi M; Umezawa K
Clin Cancer Res; 2005 Feb; 11(3):1287-93. PubMed ID: 15709200
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of tumor growth by NF-kappaB inhibitors.
Umezawa K
Cancer Sci; 2006 Oct; 97(10):990-5. PubMed ID: 16925581
[TBL] [Abstract][Full Text] [Related]
4. NF-κB and the link between inflammation and cancer.
DiDonato JA; Mercurio F; Karin M
Immunol Rev; 2012 Mar; 246(1):379-400. PubMed ID: 22435567
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of a novel nuclear factor-kappa B activation inhibitor in bladder cancer cells.
Horiguchi Y; Kuroda K; Nakashima J; Murai M; Umezawa K
Expert Rev Anticancer Ther; 2003 Dec; 3(6):793-8. PubMed ID: 14686701
[TBL] [Abstract][Full Text] [Related]
6. NF-κB signaling in cancer stem cells: a promising therapeutic target?
Vazquez-Santillan K; Melendez-Zajgla J; Jimenez-Hernandez L; Martínez-Ruiz G; Maldonado V
Cell Oncol (Dordr); 2015 Oct; 38(5):327-39. PubMed ID: 26318853
[TBL] [Abstract][Full Text] [Related]
7. Concurrent blockade of NF-κB and Akt pathways potentiates cisplatin's antitumor activity in vivo.
Sun H; Zheng X; Wang Q; Yan J; Li D; Zhou Y; Lin Y; Zhang L; Wang X
Anticancer Drugs; 2012 Nov; 23(10):1039-46. PubMed ID: 22760211
[TBL] [Abstract][Full Text] [Related]
8. Artesunate enhances TRAIL-induced apoptosis in human cervical carcinoma cells through inhibition of the NF-κB and PI3K/Akt signaling pathways.
Thanaketpaisarn O; Waiwut P; Sakurai H; Saiki I
Int J Oncol; 2011 Jul; 39(1):279-85. PubMed ID: 21537836
[TBL] [Abstract][Full Text] [Related]
9. Concurrent blockade of the NF-kappaB and Akt pathways potently sensitizes cancer cells to chemotherapeutic-induced cytotoxicity.
He HN; Wang X; Zheng XL; Sun H; Shi XW; Zhong YJ; Huang B; Yang L; Li JK; Liao LC; Zhang L; Hu LN; Lin Y
Cancer Lett; 2010 Sep; 295(1):38-43. PubMed ID: 20207071
[TBL] [Abstract][Full Text] [Related]
10. NF-κB Signaling Pathway Inhibitors as Anticancer Drug Candidates.
de Castro Barbosa ML; da Conceicao RA; Fraga AGM; Camarinha BD; de Carvalho Silva GC; Lima AGF; Cardoso EA; de Oliveira Freitas Lione V
Anticancer Agents Med Chem; 2017; 17(4):483-490. PubMed ID: 27481554
[TBL] [Abstract][Full Text] [Related]
11. Using NF-κB as a molecular target for theranostics in radiation oncology research.
Liu YC; Chiang IT; Hsu FT; Hwang JJ
Expert Rev Mol Diagn; 2012 Mar; 12(2):139-46. PubMed ID: 22369374
[TBL] [Abstract][Full Text] [Related]
12. Possible role of peritoneal NF-κB in peripheral inflammation and cancer: lessons from the inhibitor DHMEQ.
Umezawa K
Biomed Pharmacother; 2011 Jul; 65(4):252-9. PubMed ID: 21723080
[TBL] [Abstract][Full Text] [Related]
13. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
[TBL] [Abstract][Full Text] [Related]
14. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression.
Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA
Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392
[TBL] [Abstract][Full Text] [Related]
15. Regulation of COX-2 protein expression by Akt in endometrial cancer cells is mediated through NF-kappaB/IkappaB pathway.
St-Germain ME; Gagnon V; Parent S; Asselin E
Mol Cancer; 2004 Mar; 3():7. PubMed ID: 15016316
[TBL] [Abstract][Full Text] [Related]
16. Reversal of resistance to cytotoxic cancer therapies: DHMEQ as a chemo-sensitizing and immuno-sensitizing agent.
Katsman A; Umezawa K; Bonavida B
Drug Resist Updat; 2007; 10(1-2):1-12. PubMed ID: 17306602
[TBL] [Abstract][Full Text] [Related]
17. Regulation of apoptosis pathways in cancer stem cells.
Fulda S
Cancer Lett; 2013 Sep; 338(1):168-73. PubMed ID: 22429999
[TBL] [Abstract][Full Text] [Related]
18. Wasabi-derived 6-(methylsulfinyl)hexyl isothiocyanate induces apoptosis in human breast cancer by possible involvement of the NF-κB pathways.
Fuke Y; Hishinuma M; Namikawa M; Oishi Y; Matsuzaki T
Nutr Cancer; 2014; 66(5):879-87. PubMed ID: 24895898
[TBL] [Abstract][Full Text] [Related]
19. 9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-kappaB and p53 pathways.
Guo C; Gasparian AV; Zhuang Z; Bosykh DA; Komar AA; Gudkov AV; Gurova KV
Oncogene; 2009 Feb; 28(8):1151-61. PubMed ID: 19137016
[TBL] [Abstract][Full Text] [Related]
20. Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling pathways.
Lai WW; Hsu SC; Chueh FS; Chen YY; Yang JS; Lin JP; Lien JC; Tsai CH; Chung JG
Anticancer Res; 2013 May; 33(5):1941-50. PubMed ID: 23645742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
